These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17052019)

  • 41. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
    Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
    Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels.
    Jansen PJ; Lütjohann D; Thelen KM; von Bergmann K; van Leuven F; Ramaekers FC; Monique M
    J Alzheimers Dis; 2009; 18(2):319-29. PubMed ID: 19584433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small molecule TBTC as a new selective retinoid X receptor α agonist improves behavioral deficit in Alzheimer's disease model mice.
    Sun Y; Fan J; Zhu Z; Guo X; Zhou T; Duan W; Shen X
    Eur J Pharmacol; 2015 Sep; 762():202-13. PubMed ID: 26026644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain region-dependent increases in beta-amyloid and apolipoprotein E levels in hypercholesterolemic rabbits.
    Wu CW; Liao PC; Lin C; Kuo CJ; Chen ST; Chen HI; Kuo YM
    J Neural Transm (Vienna); 2003 Jun; 110(6):641-9. PubMed ID: 12768359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins.
    Vedhachalam C; Narayanaswami V; Neto N; Forte TM; Phillips MC; Lund-Katz S; Bielicki JK
    Biochemistry; 2007 Mar; 46(10):2583-93. PubMed ID: 17305370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New approach for the studies on Alzheimer's disease: a beta 1-42 and acetylcholine].
    Hoshi M
    Seikagaku; 1997 Mar; 69(3):181-7. PubMed ID: 9125900
    [No Abstract]   [Full Text] [Related]  

  • 48. [Alzheimer's disease, cerebral blood flow, and nitric oxide].
    Toda N; Ayajiki K
    Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):20-4. PubMed ID: 20075566
    [No Abstract]   [Full Text] [Related]  

  • 49. [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):455-7. PubMed ID: 11523146
    [No Abstract]   [Full Text] [Related]  

  • 50. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
    Wang N; Lan D; Chen W; Matsuura F; Tall AR
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adipocyte modulation of high-density lipoprotein cholesterol.
    Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
    Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives.
    Dong HK; Gim JA; Yeo SH; Kim HS
    Gene; 2017 Jan; 597():10-16. PubMed ID: 27773727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E, A beta, and Alzheimer disease.
    Hyman BT; Terry RD
    J Neuropathol Exp Neurol; 1994 Sep; 53(5):427-8. PubMed ID: 8083685
    [No Abstract]   [Full Text] [Related]  

  • 55. Alzheimer's: could there be a zinc link?
    Kaiser J
    Science; 1994 Sep; 265(5177):1365. PubMed ID: 8073269
    [No Abstract]   [Full Text] [Related]  

  • 56. The ABCs of beta-cell dysfunction in type 2 diabetes.
    Chakravarthy MV; Semenkovich CF
    Nat Med; 2007 Mar; 13(3):241-2. PubMed ID: 17342111
    [No Abstract]   [Full Text] [Related]  

  • 57. Microbes and Alzheimer's Disease.
    Itzhaki RF; Lathe R; Balin BJ; Ball MJ; Bearer EL; Braak H; Bullido MJ; Carter C; Clerici M; Cosby SL; Del Tredici K; Field H; Fulop T; Grassi C; Griffin WS; Haas J; Hudson AP; Kamer AR; Kell DB; Licastro F; Letenneur L; Lövheim H; Mancuso R; Miklossy J; Otth C; Palamara AT; Perry G; Preston C; Pretorius E; Strandberg T; Tabet N; Taylor-Robinson SD; Whittum-Hudson JA
    J Alzheimers Dis; 2016; 51(4):979-84. PubMed ID: 26967229
    [No Abstract]   [Full Text] [Related]  

  • 58. Alzheimer's amyloid beta and lipid metabolism: a missing link?
    Koudinov AR; Berezov TT; Koudinova NV
    FASEB J; 1998 Sep; 12(12):1097-9. PubMed ID: 9737712
    [No Abstract]   [Full Text] [Related]  

  • 59. Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer's Disease.
    Jaouen F; Gascon E
    J Neurosci; 2016 Mar; 36(9):2558-60. PubMed ID: 26936997
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention: activity is the best medicine.
    Deweerdt S
    Nature; 2011 Jul; 475(7355):S16-7. PubMed ID: 21760577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.